Stock Events

Stock Events

Silence Therapeutics (SLN) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.09

-0.05

-0.01

0.02

Details

Expected EPS

-0.050972922

Actual EPS

-0.064691235

Surprise EPS

-0.01

Surprise Percent

+26.91%

Description

Silence Therapeutics (SLN) has reported earnings of -0.064691235 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.